Lactase-Assisted Control Trial On Weight GAin in INfants.

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 27, 2025

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2027

Conditions
Premature - Weight 1000g-2499g or Gestation of 28-37weeksHealthy
Interventions
DIETARY_SUPPLEMENT

Lactase

The lactase drops that will be used in the study will be Delictase®, which is a dietary supplement that helps the proper digestion of lactose through its breakdown. Delictase® lactase drops offer an exogenous source of the lactase enzyme, which is essential for the proper absorption and digestion of lactose, can be administered from birth, mixed into the administered milk and contain high levels of lactase (\>3,000 ALU\*). The supply of Delictase® lactase preparations will be carried out by Galenic Pharmacy, every 2 months at the study site.

Trial Locations (2)

Unknown

ACTIVE_NOT_RECRUITING

Papageorgiou General Hospital, Thessaloniki

RECRUITING

Papageorgiou General Hospital, Thessaloniki

All Listed Sponsors
lead

Aristotle University Of Thessaloniki

OTHER

NCT07150884 - Lactase-Assisted Control Trial On Weight GAin in INfants. | Biotech Hunter | Biotech Hunter